Prescribing measures

This list is filtered to show only measures tagged: Safety.

Improving safety is about reducing risk and minimising mistakes. The World Health Organisation has launched its third patient safety challenge Medication Without Harm. Changes in the following measures may result in reduction of the risk of harm to patients and contribute to WHOs ambition in reducting medication related harm by 50% within 5 years.

Show all measures.

Show measures categorised as:

See prescribing by all Sub-ICB Locations for:

Antibiotic stewardship: fluoroquinolone items per 1000 patients
Anxiolytics and Hypnotics: Average Daily Quantity per 1000 patients
Anxiolytics and Hypnotics: Average Daily Quantity per item
Ciclosporin and tacrolimus oral preparations prescribed generically
Co-proxamol
Diltiazem preparations (>60mg) prescribed generically
High dose inhaled corticosteroids
High dose opioid items as percentage regular opioids
High dose opioids per 1000 patients
Higher dose Proton Pump Inhibitors (PPIs)
Items which should not routinely be prescribed in primary care - amiodarone
Items which should not routinely be prescribed in primary care - co-proxamol
Items which should not routinely be prescribed in primary care - dosulepin
Items which should not routinely be prescribed in primary care - dronedarone
Items which should not routinely be prescribed in primary care - immediate release fentanyl
Items which should not routinely be prescribed in primary care - minocycline
Methotrexate 10 mg tablets
Non-preferred NSAIDs and COX-2 inhibitors
Possible excess quantities of semaglutide
Prescribing of gabapentin and pregabalin (DDD)
Prescribing of opioids (total oral morphine equivalence)
Prescribing of pregabalin (total mg)
Seven Day Prescribing for Long Term Conditions
Short acting beta agonist inhalers
Ulipristal acetate 5mg prescribing for uterine fibroids
Zuclopenthixol acetate prescribing in primary care